Trial in Progress: a Phase II, Multicenter, Single-Arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib.
Journal of Clinical Oncology（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要